139 related articles for article (PubMed ID: 23651635)
1. A survivin-associated adaptive response in radiation therapy.
Grdina DJ; Murley JS; Miller RC; Mauceri HJ; Sutton HG; Li JJ; Woloschak GE; Weichselbaum RR
Cancer Res; 2013 Jul; 73(14):4418-28. PubMed ID: 23651635
[TBL] [Abstract][Full Text] [Related]
2. NFκB and Survivin-Mediated Radio-Adaptive Response.
Grdina DJ; Murley JS; Miller RC; Woloschak GE; Li JJ
Radiat Res; 2015 Apr; 183(4):391-7. PubMed ID: 25763931
[TBL] [Abstract][Full Text] [Related]
3. Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity.
Miller RC; Murley JS; Rademaker AW; Woloschak GE; Li JJ; Weichselbaum RR; Grdina DJ
Free Radic Biol Med; 2016 Oct; 99():110-119. PubMed ID: 27427516
[TBL] [Abstract][Full Text] [Related]
4. A manganese superoxide dismutase (SOD2)-mediated adaptive response.
Grdina DJ; Murley JS; Miller RC; Mauceri HJ; Sutton HG; Thirman MJ; Li JJ; Woloschak GE; Weichselbaum RR
Radiat Res; 2013 Feb; 179(2):115-24. PubMed ID: 23237540
[TBL] [Abstract][Full Text] [Related]
5. ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive response.
Murley JS; Arbiser JL; Weichselbaum RR; Grdina DJ
Free Radic Biol Med; 2018 Aug; 123():39-52. PubMed ID: 29660403
[TBL] [Abstract][Full Text] [Related]
6. TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response.
Murley JS; Miller RC; Weichselbaum RR; Grdina DJ
Radiat Res; 2017 Nov; 188(5):579-590. PubMed ID: 28813624
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Gamma Radiation Does Not Induce an Adaptive Response for Micronucleus Induction in Mouse Splenocytes.
Bannister LA; Serran ML; Mantha RR
Radiat Res; 2015 Nov; 184(5):533-44. PubMed ID: 26495871
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
9. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
Sun HB; Zheng HY; Yan X
Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
[TBL] [Abstract][Full Text] [Related]
10. Dose and Radioadaptive Response Analysis of Micronucleus Induction in Mouse Bone Marrow.
Bannister LA; Mantha RR; Devantier Y; Petoukhov ES; Brideau CL; Serran ML; Klokov DY
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649149
[TBL] [Abstract][Full Text] [Related]
11. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
[TBL] [Abstract][Full Text] [Related]
12. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
13. Biological effects and adaptive response from single and repeated computed tomography scans in reticulocytes and bone marrow of C57BL/6 mice.
Phan N; De Lisio M; Parise G; Boreham DR
Radiat Res; 2012 Feb; 177(2):164-75. PubMed ID: 22059980
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Survivin Gene Expression Affects Ionizing Radiation Resistance of Human T98 Glioma Cells.
Li J; Han Y; Zhou D; Zhou Y; Ye M; Wang H; Du Z
Cell Mol Neurobiol; 2018 May; 38(4):861-868. PubMed ID: 29098505
[TBL] [Abstract][Full Text] [Related]
15. Heavy ion beams induce survivin expression in human hepatoma SMMC-7721 cells more effectively than X-rays.
Gong L; Jin X; Li Q; Liu J; An L
Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):575-82. PubMed ID: 17687492
[TBL] [Abstract][Full Text] [Related]
16. Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation.
Gurley KE; Ashley AK; Moser RD; Kemp CJ
Cell Death Differ; 2017 Nov; 24(11):1853-1860. PubMed ID: 28686579
[TBL] [Abstract][Full Text] [Related]
17. Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma.
Greve B; Sheikh-Mounessi F; Kemper B; Ernst I; Götte M; Eich HT
Strahlenther Onkol; 2012 Nov; 188(11):1038-47. PubMed ID: 23053158
[TBL] [Abstract][Full Text] [Related]
18. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin.
Chun KS; Langenbach R
Mol Carcinog; 2011 Jun; 50(6):439-48. PubMed ID: 21268125
[TBL] [Abstract][Full Text] [Related]
19. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
[TBL] [Abstract][Full Text] [Related]
20. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
